Summary

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis

Published: May 05, 2023
doi:

Summary

The current study describes a protocol to monitor the changes in human umbilical vein endothelial cells (HUVECs) during viral infection using a real-time cell analysis (RTCA) system.

Abstract

Endothelial cells line the inner surface of all blood and lymphatic vessels, creating a semi-permeable barrier regulating fluid and solute exchange between blood or lymph and their surrounding tissues. The ability of a virus to cross the endothelial barrier is an important mechanism that facilitates virus dissemination in the human body. Many viruses are reported to alter endothelial permeability and/or cause endothelial cell barrier disruption during infection, which is able to cause vascular leakage. The current study describes a real-time cell analysis (RTCA) protocol, using a commercial real-time cell analyzer to monitor endothelial integrity and permeability changes during Zika virus (ZIKV) infection of the human umbilical vein endothelial cells (HUVECs). The impedance signals recorded before and after ZIKV infection were translated to cell index (CI) values and analyzed. The RTCA protocol allows the detection of transient effects in the form of cell morphological changes during a viral infection. This assay could also be useful for studying changes in the vascular integrity of HUVECs in other experimental setups.

Introduction

Endothelial cells (ECs) line the inner surface of all blood and lymphatic vessels. They are connected by adherens, tight gap junctions, creating a semi-permeable barrier between blood or lymph and the surrounding tissues1,2. The intact endothelial cell-cell junctions are critical for regulating the transport of macromolecules, solutes, and fluids, crucial for the physiological activities of the corresponding tissues and organs3. The endothelial barrier is dynamic and modulated by specific stimuli4. Disruption or loss of endothelial barrier function is a hallmark of disease pathophysiology in acute and chronic inflammation in the pathogenesis of many diseases5,6,7, including viral infection8,9,10,11. For flaviviruses, it was found that the non-structural protein NS1 can alter endothelial permeability, for example, via disruption of the endothelial glycocalyx-like layer as a result of increased expression and activation of cathepsin L, sialidases, and endoglycosidase heparinase9. In the disease state, the integrity of the endothelial monolayer is affected, and cell-cell junctions are disrupted, which may lead to endothelial injury and dysfunction12 and eventually widespread pathological manifestations across multiple organ systems13,14. Viral infection of ECs results in changes in the cell signaling pathways and cellular gene expression profile, which may affect the fluid barrier functions, cause disruption of the ECs, and induce vascular leakage10,15. Zika virus (ZIKV) infection of ECs has been found to disrupt the junctional integrity that causes changes in vascular permeability and lead to endothelial barrier dysfunction, resulting in vascular leakage10,15. Studies have shown that ZIKV is linked to severe birth defects; however, not much is known about the exact mechanism by which this occurs16,17. Understanding endothelial barrier changes during an infection is therefore critical to understand the disease mechanism.

ECs are currently used as an important experimental in vitro vascular model system for various physiological and pathological processes18,19,20,21. Human umbilical vein endothelial cells (HUVECs) have been extensively used as a primary, non-immortalized cell system to study the vascular endothelium and vascular biology in vitro22,23,24,25. HUVECs were first isolated for in vitro culture in the early 1970s from the umbilical vein of the human umbilical cord26. HUVECs have a cobblestone-like morphology that is easily made to proliferate in the laboratory. Due to shear stress after being maintained for long periods in the confluent state, elongation of the cell shape is observed. HUVECs can be characterized by the presence of Weibel and Palade bodies (WPB), pinocytic vesicles, small amounts of fibrils located near the nucleus, mitochondria with tubular shapes which rarely show ramifications, an ellipsoid nucleus with a fine granular pattern of condensed chromatin, and one to three nucleoli present in each nucleus27. Although HUVECs show numerous morphological characteristics, the identification of HUVECs cannot be achieved by optic examination alone. Assays, such as immunofluorescence staining of vascular endothelial (VE)-cadherin, is commonly used for the monitoring of vascular integrity in HUVECs28,29,30,31.

This study describes the real-time cell analysis (RTCA) protocol of the infection of HUVECs. The RTCA system uses specialized gold-coated plates containing microelectrodes that provide a conductive surface for the cell attachment. When the cells attach to the microelectrode surface, a barrier that impedes electron flow through the microelectrodes is formed. Measurement of the impedance generated by microelectrodes can be used to gain information on some cellular processes, including cell attachments, proliferation, and migration32. The reported assay is an impedance-based cellular assay that, coupled with a real-time cell analyzer, provides continuous measurement of live cell proliferation, morphology changes (such as cell shrinking) and cell attachment quality in a noninvasive and label-free manner. In this study, the real-time cell analyzer is used to monitor the endothelial integrity and morphological changes of HUVECs during ZIKV infection. Briefly, the instrument measures electron flow transmitted in specialized gold-microelectrode-coated microtiter plates in the presence of a culture medium (electrically conductive solution). Cell adherence or changes in cell number and morphology disturb the electron flow and cause impedance variations that can be captured by the instrument (Supplementary Figure 1). The difference between HUVEC growth, proliferation, and adherence before and after ZIKV infection is recorded in real time by an electrical impedance signal and then translated to cell index (CI) value. The CI value from the pre-infection is used as the baseline for CI value normalization. The changes in CI values reflect cellular morphological changes or cell adherence loss upon the infection33. The study results show that the RTCA protocol allows the detection of transient effects or cell morphological changes during viral infection compared to an endpoint assay, such as immunofluorescence staining of VE-cadherin. The RTCA method could be useful for analyzing the HUVEC vascular integrity changes upon infection by other viruses.

Protocol

1. Cell preparation Preparation of HUVECs Grow 7.5 x 105 HUVEC cells/mL in a 75 cm2 (coated with 20 µg/mL collagen type 1) cell culture flask containing 12 mL of endothelial cell medium (ECM) supplemented with 10% fetal bovine serum (FBS), 0.01% endothelial cell growth supplement (ECGS) that contains growth factors, hormones, and proteins necessary for the culture of HUVECs, and 0.01% penicillin-streptomycin (P/S). Incubate the cells in a cell culture in…

Representative Results

Before ZIKV infection, the CI recorded for the HUVEC monolayer cultured on a specialized gold-microelectrode coated microtiter plate was above 8, suggesting strong adherence properties. Plates or wells with a CI index less than 8 should be discarded. The HUVECs were then infected with ZIKV at an MOI of 0.1 and 1, and the cell impedance was recorded for 7 days. The CI value of HUVECs infected with ZIKV P6-740 at an MOI of 0.1 (light blue line) started to drop at 15 h post-infection (HPI), compared to the negative infectio…

Discussion

Cytocidal viral infection in permissive cells is usually associated with substantial changes in cell morphology and biosynthesis36. The virus-induced cellular morphological changes, such as cell shrinking, cell enlargement, and/or syncytia formation, are also known as cytopathic effects (CPEs), characteristic to certain viral infections37. In ECs, the CPE was described as the destruction of cells and breakdown of the tight junctions in between each EC, hence causing the bre…

Disclosures

The authors have nothing to disclose.

Acknowledgements

This research received support from the Ministry of Higher Education Malaysia under the Higher Institution Centre of Excellence (HICoE) program (MO002-2019) and funding under the Long-Term Research Grant Scheme (LRGS MRUN Phase 1: LRGS MRUN/F1/01/2018).

Materials

1.5 mL microcentrifuge tube Nest 615601
37 °C incubator with 5% CO2 Sanyo MCO-18AIC
75 cm2 tissue culture flask  Corning 430725U
Antibiotic solution penicillin-streptomycin (P/S) Sciencell 0503
Biological safety cabinet, Class II Holten HB2448
Collagen Type 1 SIgma-Aldrich C3867
Endothelial cell growth supplement (ECGS) Sciencell 1052
Endothelial cell medium (ECM) Sciencell 1001
E-plate 96 Agilent Technologies, Inc. 05232368001
Fetal bovine serum (FBS) Sciencell 0025
Hanks' Balanced Salt Solution (HBSS) Sigma-Aldrich H9394
Hemocytometer Laboroptik LTD Neubauer improved
Human Umbilical Vein Endothelial Cells (HUVECs) Sciencell 8000
Inverted microscope ZEISS TELAVAL 31
Latitude 3520 Laptop Dell 
Multichannel micropipette (10 – 100 µL) Eppendorf 3125000036
Multichannel micropipette (30 – 300 µL) Eppendorf 3125000052
Reagent reservior Tarsons T38-524090
RTCA resistor plate 96 Agilent Technologies, Inc. 05232350001
RTCA Software Pro (Version 2.6.1) Agilent Technologies, Inc. 5454433001
Single channel pipettes (10 – 100 µL) Eppendorf 3123000047
Single channel pipettes (100 – 1000 µL) Eppendorf 3123000063
Single channel pipettes (20 – 200 µL) Eppendorf 3123000055
xCELLigence Real-time cell analyzer SP (Model: W380) Agilent Technologies, Inc. 00380601030 https://www.agilent.com/en/product/cell-analysis/real-time-cell-analysis/rtca-analyzers/xcelligence-rtca-sp-single-plate-741232

References

  1. Alberts, B., et al. Cell junctions. Molecular Biology of the Cell. 4th Edition. , (2002).
  2. Pugsley, M. K., Tabrizchi, R. The vascular system: An overview of structure and function. Journal of Pharmacological and Toxicological Methods. 44 (2), 333-340 (2000).
  3. Stevens, T., Garcia, J. G., Shasby, D. M., Bhattacharya, J., Malik, A. B. Mechanisms regulating endothelial cell barrier function. American Journal of Physiology. Lung Cellular and Molecular Physiology. 279 (3), L419-L422 (2000).
  4. Wu, M. H. Endothelial focal adhesions and barrier function. The Journal of Physiology. 569, 359-366 (2005).
  5. Boueiz, A., Hassoun, P. M. Regulation of endothelial barrier function by reactive oxygen and nitrogen species). Microvascular Research. 77 (1), 26-34 (2009).
  6. Fosse, J. H., Haraldsen, G., Falk, K., Edelmann, R. Endothelial cells in emerging viral infections. Frontiers in Cardiovascular Medicine. 8, 619690 (2021).
  7. Rajendran, P., et al. The vascular endothelium and human diseases. International Journal of Biological Sciences. 9 (10), 1057-1069 (2013).
  8. Iyer, S., Ferreri, D. M., DeCocco, N. C., Minnear, F. L., Vincent, P. A. VE-cadherin-p120 interaction is required for maintenance of endothelial barrier function. American Journal of Physiology. Lung Cellular and Molecular Physiology. 286 (6), L1143-L1153 (2004).
  9. Puerta-Guardo, H., et al. Flavivirus NS1 triggers tissue-specific vascular endothelial dysfunction reflecting disease tropism. Cell Reports. 26 (6), 1598-1613 (2019).
  10. Rastogi, M., Singh, S. K. Zika virus NS1 affects the junctional integrity of human brain microvascular endothelial cells. Biochimie. 176, 52-61 (2020).
  11. Soe, H. J., et al. High dengue virus load differentially modulates human microvascular endothelial barrier function during early infection. Journal of General Virology. 98 (12), 2993-3007 (2017).
  12. Krouwer, V. J., Hekking, L. H. P., Langelaar-Makkinje, M., Regan-Klapisz, E., Post, J. A. Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability. Vascular Cell. 4 (1), 12 (2012).
  13. Aird, W. C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 101 (10), 3765-3777 (2003).
  14. Bryce, C., et al. Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience. MedRxiv. , (2020).
  15. Khaiboullina, S., et al. Transcriptome profiling reveals pro-inflammatory cytokines and matrix metalloproteinase activation in Zika virus infected human umbilical vein endothelial cells. Frontiers in Pharmacology. 10, 642 (2019).
  16. Cao-Lormeau, V. -. M., et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. The Lancet. 387 (10027), 1531-1539 (2016).
  17. Sarno, M., et al. Zika virus infection and stillbirths: a case of hydrops fetalis, hydranencephaly and fetal demise. PLoS Neglected Tropical Diseases. 10 (2), e0004517 (2016).
  18. Dalrymple, N. A., Mackow, E. R. Virus interactions with endothelial cell receptors: implications for viral pathogenesis. Current Opinion in Virology. 7, 134-140 (2014).
  19. Buchanan, C. F., et al. Three-dimensional microfluidic collagen hydrogels for investigating flow-mediated tumor-endothelial signaling and vascular organization. Tissue Engineering Part C: Methods. 20 (1), 64-75 (2014).
  20. Daniels, B. P., et al. Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro model of immune migration across the blood brain barrier. Journal of Neuroscience Methods. 212 (1), 173-179 (2013).
  21. Vozzi, F., Bianchi, F., Ahluwalia, A., Domenici, C. Hydrostatic pressure and shear stress affect endothelin-1 and nitric oxide release by endothelial cells in bioreactors. Biotechnology Journal. 9 (1), 146-154 (2014).
  22. Gallinat, A., Badimon, L. DJ-1 interacts with the ectopic ATP-synthase in endothelial cells during acute ischemia and reperfusion. Scientific Reports. 12 (1), 12753 (2022).
  23. Jiménez, N., Krouwer, V. J. D., Post, J. A. A new, rapid and reproducible method to obtain high quality endothelium in vitro. Cytotechnology. 65 (1), 1-14 (2013).
  24. Latifi-Navid, H., et al. Network analysis and the impact of Aflibercept on specific mediators of angiogenesis in HUVEC cells. Journal of Cellular and Molecular Medicine. 25 (17), 8285-8299 (2021).
  25. Poulet, M., et al. PRL-2 phosphatase is required for vascular morphogenesis and angiogenic signaling. Communications Biology. 3 (1), 603 (2020).
  26. Laurens, N., van Hinsbergh, V. W. Isolation, purification and culture of human micro- and macrovascular endothelial cells. Methods in Endothelial Cell Biology. , 3-13 (2004).
  27. Haudenschild, C. C., Zahniser, D., Folkman, J., Klagsbrun, M. Human vascular endothelial cells in culture: lack of response to serum growth factors. Experimental Cell Research. 98 (1), 175-183 (1976).
  28. Cenni, E., Perut, F., Baldini, N. In vitro models for the evaluation of angiogenic potential in bone engineering. Acta Pharmacologica Sinica. 32 (1), 21-30 (2011).
  29. Lau, S., Gossen, M., Lendlein, A., Jung, F. Venous and arterial endothelial cells from human umbilical cords: potential cell sources for cardiovascular research. International Journal of Molecular Sciences. 22 (2), 978 (2021).
  30. Marquez-Curtis, L. A., Sultani, A. B., McGann, L. E., Elliott, J. A. W. Beyond membrane integrity: Assessing the functionality of human umbilical vein endothelial cells after cryopreservation. Cryobiology. 72 (3), 183-190 (2016).
  31. Park, H. -. J., et al. Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis. Stem Cell Reviews. 2 (2), 93-102 (2006).
  32. Dowling, C. M., Herranz Ors, C., Kiely, P. A. Using real-time impedance-based assays to monitor the effects of fibroblast-derived media on the adhesion, proliferation, migration and invasion of colon cancer cells. Bioscience Reports. 34 (4), e00126 (2014).
  33. Piret, J., Goyette, N., Boivin, G. Novel method based on real-time cell analysis for drug susceptibility testing of herpes simplex virus and human cytomegalovirus. Journal of Clinical Microbiology. 54 (8), 2120-2127 (2016).
  34. Tan, J. Y., Wong, J. E., Zainal, N., AbuBakar, S., Tan, K. K. Virus propagation and cell-based colorimetric quantification. Journal of Visualized Experiments. , (2023).
  35. Kustermann, S., et al. A real-time impedance-based screening assay for drug-induced vascular leakage. Toxicological Sciences. 138 (2), 333-343 (2014).
  36. Albrecht, T., Fons, M., Boldogh, I., Rabson, A. S. Effects on cells. Medical Microbiology. 4th Edition. , (1996).
  37. Hematian, A., et al. Traditional and modern cell culture in virus diagnosis. Osong Public Health and Research Perspectives. 7 (2), 77-82 (2016).
  38. Friedman, H. M. Infection of endothelial cells by common human viruses. Reviews of Infectious Diseases. 11, S700-S704 (1989).
  39. Friedman, H. M., Macarak, E. J., MacGregor, R. R., Wolfe, J., Kefalides, N. A. Virus infection of endothelial cells. The Journal of Infectious Diseases. 143 (2), 266-273 (1981).
  40. Xiao, C., Lachance, B., Sunahara, G., Luong, J. H. T. Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. Analytical Chemistry. 74 (22), 5748-5753 (2002).
  41. Marlina, S., Shu, M. -. H., AbuBakar, S., Zandi, K. Development of a Real-Time Cell Analysing (RTCA) method as a fast and accurate screen for the selection of chikungunya virus replication inhibitors. Parasites & Vectors. 8, 579 (2015).
  42. Liu, S., DeLalio, L. J., Isakson, B. E., Wang, T. T. AXL-mediated productive infection of human endothelial cells by Zika virus. Circulation Research. 119 (11), 1183-1189 (2016).
  43. Souf, S. Recent advances in diagnostic testing for viral infections. Bioscience Horizons: The International Journal of Student Research. 9, (2016).
  44. Sun, M., et al. A dynamic real-time method for monitoring epithelial barrier function in vitro. Analytical Biochemistry. 425 (2), 96-103 (2012).
  45. Stefanowicz-Hajduk, J., Ochocka, J. R. Real-time cell analysis system in cytotoxicity applications: Usefulness and comparison with tetrazolium salt assays. Toxicology Reports. 7, 335-344 (2020).
  46. Kho, D., et al. Application of xCELLigence RTCA biosensor technology for revealing the profile and window of drug responsiveness in real time. Biosensors. 5 (2), 199-222 (2015).
check_url/64887?article_type=t

Play Video

Cite This Article
Wong, J., Zainal, N., AbuBakar, S., Tan, K. Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis. J. Vis. Exp. (195), e64887, doi:10.3791/64887 (2023).

View Video